Blood Urea Nitrogen: A Marker for Adverse Effects of Loop Diuretics?

Journal of the American College of Cardiology

Volumn 58, Issue 4, 2011, Pages 383-385

  Lindenfeld, JoAnn ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

congestive heart failure; kidney; loop diuretics; mortality

Indexed keywords

BIOLOGICAL MARKER; CREATININE; LOOP DIURETIC AGENT;

BLOOD; HEART FAILURE; HUMAN; NOTE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; HEART FAILURE; HUMANS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 80053326699     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.01.054     Document Type: Editorial

References (26)

1. Ahmed, A., Husain, A., Love, T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006), 1431–1439.
2. Eshaghian, S., Horwich, T.B., Fonarow, G.C., Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97 (2006), 1759–1764.
3. Domanski, M., Norman, J., Pitt, B., Haigney, M., Hanlon, S., Peyster, E., Studies of left ventricular dysfunction: Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42 (2003), 705–708.
4. He, X.R., Greenberg, S.G., Briggs, J.P., Schnermann, J., Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension 26 (1995), 137–142.
5. Testani, J.M., Cappola, T.P., Brensinger, C.M., Shannon, R.P., Kimmel, S.E., Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol 58 (2011), 375–382.
6. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 (2001), 1659–1667.
7. Berl, T., Schrier, R.W., Disorders of water metabolism. Schrier, R.W., (eds.) Renal and Electrolyte Disorders, 6th edition, 2002, Lippincott Williams & Wilkins, Philadelphia, PA, 1–63.
8. Schrier, R.W., Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1 (2008), 2–5.
9. Klein, L., Massie, B.M., Leimberger, J.D., et al., OPTIME-CHF Investigators. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 1 (2008), 25–33.
10. Heywood, J.T., Elatre, W., Pai, R.G., Fabbri, S., Huiskes, B., Simple clinical criteria to determine the prognosis of heart failure. J Cardiovasc Pharmacol Ther 10 (2005), 173–180.
11. Filippatos, G., Rossi, J., Lloyd-Jones, D.M., et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail 13 (2007), 360–364.
12. Giamouzis, G., Kalogeropoulos, A.P., Georgiopoulou, V.V., et al. Incremental value of renal function in risk prediction with the Seattle Heart Failure Model. Am Heart J 157 (2009), 299–305.
13. Cauthen, C.A., Lipinski, M.J., Abbate, A., et al. Relation of blood urea nitrogen to long-term mortality in patients with heart failure. Am J Cardiol 101 (2008), 1643–1647.
14. Schrier, R.W., Cardiorenal versus renocardiac syndrome: is there a difference?. Nat Clin Pract Nephrol, 3, 2007, 637.
15. Lindenfeld, J., Schrier, R.W., The kidney in heart failure. Hosenpud, J.D., Greenberg, B.H., (eds.) Congestive Heart Failure, 3rd edition, 2002, Lippincott Williams & Wilkins, Philadelphia, PA, 243–260.
16. DiBona, G.F., Physiology in perspective: the wisdom of the body: Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289 (2005), R633–R641.
17. Schrier, R.W., Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006), 1–8.
18. Sands, J.M., Mammalian urea transporters. Ann Rev Physiol 65 (2003), 543–566.
19. Schrier, R.W., De Wardener, H.E., Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. N Engl J Med 285 (1971), 1292–1303.
20. Firth, J.D., Raine, A.E., Ledingham, J.G., Raised venous pressure: a direct cause of renal sodium retention in oedema?. Lancet 1 (1988), 1033–1035.
21. Leithe, M.E., Margorien, R.D., Hermiller, J.B., Unverferth, D.V., Leier, C.V., Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 69 (1984), 57–64.
22. Marenzi, G., Lauri, G., Guazzi, M., et al. Inhibition of the neurohumoral axis after intravascular fluid depletion in congestive heart failure with water retention: mechanisms of the perpetuation of the syndrome. Cardiologia 40 (1995), 15–22.
23. Agostoni, P., Marenzi, G., Lauri, G., et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 96 (1994), 191–199.
24. Brater, D.C., Diuretic therapy. N Engl J Med 339 (1998), 387–395.
25. Francis, G.S., Benedict, C., Johnstone, D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990), 1724–1729.
26. Anand, I.S., Fisher, L.D., Chiang, Y.T., et al., Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003), 1278–1283.